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Barakat syndrome (also known as HDR syndrome) is an autosomal dominant disorder characterized by hypoparathyroidism,
sensorineural deafness, and renal disease caused bymutation of theGATA3 gene located at chromosome 10p15.The exact prevalence
of this disorder is not known but is very rare, with only about a dozen cases reported in the literature. Here, we report a case of 58-
year-oldman fromArdabil who presentedwith seizure due to hypocalcemia. Further history revealed bilateral deafness. Audiogram
confirmed sensorineural hearing loss of both sides. His laboratory data were consistent with hypoparathyroidism and renal failure.
He was diagnosed to have Barakat syndrome based on his clinical and laboratory data. In conclusion, we need to be aware of rare
inherited conditions in a patient with abnormal physical and laboratory findings even though their initial presentation was seizure
and hypocalcemia.
1. Introduction
Barakat syndrome, also known as hypoparathyroidism, deaf-
ness, and renal dysplasia (HDR) syndrome, is a rare autoso-
mal dominant disorder [1]. The syndrome was first noted in
siblings with hypocalcemia and proteinuria [2]. Mutations in
GATA3, a gene localized to the chromosome region 10p14-
15, have been detected in families affected by the syndrome
[3, 4]. GATA3 is a transcription factor that is involved in the
embryonic development of the parathyroid glands, kidneys,
inner ears, thymus, and central nervous findings. Similar
clinical findings were reported in families with an apparent
autosomal recessive mode of inheritance [5, 6].
In this report, we demonstrate a case of Barakat syndrome
presented with seizure, hypoparathyroidism, and bilateral
sensorineural deafness.
2. Case Report
A 58-year-old man from Ardabil was admitted to our hos-
pital with generalized tonic-clonic seizure. The patient was
a known case of chronic kidney disease 2 years ago. He
had been experiencing recurrent episodes of seizure for
20 days before his admission. Further history revealed
progressive hearing loss for the last 10 years but there
was no developmental delay. He had a family history of
kidney disease in siblings, which in their renal biopsy were
reported to have FSGS. His vital signs were within the
normal range. Neurological examination showed depression
of deep tendon reflexes in both upper and lower extremities.
Chvostek’s and Trousseau’s signs were negative. The initial
laboratory studies showed serum calcium level: 5.3mg/dL
and serum phosphorus level: 7.2mg/dL. The serum intact-
PTH level measured by immunoradiometric assay (IRMA)
was 5 ng/L (normal range: 15–60 ng/L). The patient did not
have any history of neck surgery or radiation exposure that
could have led to hypoparathyroidism. Other laboratory tests
on the serum showed urea nitrogen: 30mg/dL, creatinine:
2.5mg/dL, albumin: 4.2 g/dL, sodium: 138mEq/L, potassium:
3.9mEq/L, and magnesium: 1.65mg/dL (normal range: 1.6–
2.3mg/dL). Urine volume in 24 hours was 1700mL with
urine creatinine, protein, and calcium levels of 1020mg/dL,
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Table 1: Comparison of presentation for patients with HDR syndrome.
References Symptoms Heredity Number of patients
Shaw et al. [5] Hypoparathyroidism, renal failure, anddevelopmental delay Autosomal recessive 2 girls and 2 boys
Bilous et al. [1] Deafness, hypoparathyroidism, and renaldysplasia Autosomal dominant 2 sisters and 2 brothers
Hasegawa et al. [7] Deafness, hypoparathyroidism, and renaldysplasia Autosomal dominant 1 girl
Watanabe et al. [8] Deafness, hypoparathyroidism, andwithout renal disease Autosomal dominant
One-month-old infant and
5 members of family
Fujimoto et al. [9]
Deafness, hypoparathyroidism, renal
dysplasia, and recurrent infarcts in basal
ganglia
— 1 boy
Muroya et al. [4] Deafness, hypoparathyroidism, and renaldysplasia Autosomal dominant 9 patients
Aksoylar et al. [10] Deafness, hypoparathyroidism, renaldysplasia, and psoriasis Autosomal dominant An 18-year-old girl
Kato et al. [11]
Deafness, hypoparathyroidism, renal
dysplasia, nephrocalcinosis, and renal
tubular acidosis
Autosomal dominant A 34-year-old woman
Taslipinar et al. [12] Deafness, hypoparathyroidism, renaldysplasia, and renal tubular acidosis Autosomal dominant A 19-year-old man
Figure 1: Electrocardiography showed a prolonged QT interval
(560msec).
176mg/dL, and 20mg/dL. Erythrocyte sedimentation rate
was 51 in the first hour and serumC-reactive protein level was
18mg/dL. Serum protein electrophoresis was normal. Elec-
trocardiography showed a prolonged QT interval (560 msec)
(Figure 1).
Noncontrast computed tomography of the brain showed
intracranial calcification involving the basal ganglia, thala-
mus, and cerebral cortex on both the right and left sides
(Figure 2). Pure tone audiometry showed bilateral moderate-
to-severe hearing loss that was more severe at the higher end
of the frequency spectrum (Figure 3). Abdominal ultrasonog-
raphy revealed a reduction in size of both kidneys (80mm
in length) with an increased cortical echogenicity. Because
of the simultaneous occurrence of hypoparathyroidism, deaf-
ness, and renal disease, the patient was diagnosed with HDR
syndrome. However, chromosomal study of the patient using
standard trypsin G-banding analysis showed no abnormality.
The patient was administered calcium carbonate, ergocal-
ciferol, and rocaltrol. After the sizures were controlled, he was
discharged and is being followed up.
3. Discussion
Barakat syndrome can occur at any age, and patients with this
syndrome usually show symptoms related to hypocalcemia. It
was first reported in 1977 by Barakat et al. [2]. In 1992, Bilous
et al. [1] described two brothers and two daughters of one of
the affected brotherswith hypoparathyroidism, sensorineural
deafness, and renal dysplasia. Subsequently, other reports
appeared in the literature confirming that the syndrome is
associated with a wide phenotype spectrum, consisting of
hypoparathyroidism, sensorineural deafness, and renal dis-
ease [4, 7, 9, 13, 14]. Patients may present with hypocalcemia,
tetany, or afebrile convulsions at any age. Hearing loss is
usually bilateral (but may be asymmetric) and may range
from mild to profound impairment, being more severe at
the higher end of the frequency spectrum. Renal diseases
in these patients include nephrotic syndrome, cystic kidney,
renal dysplasia, hypoplasia or aplasia, pelvicalyceal defor-
mity, vesicoureteral reflux, chronic renal failure, hematuria,
proteinuria, and renal scarring [1, 2, 11, 15–17]. However,
most patients show progression to chronic renal failure
and require renal replacement therapy [4]. Our patient had
chronic renal insufficiency. No renal dysplasia was detected
on imaging studies. Deafness is a consistent feature of HDR
syndrome. HDR patients have been reported to experience
bilateral sensorineural deafness, which is more severe at
higher frequencies [18]. Our patient also showed similar
features on PTA.
The original patients described by Barakat et al. [2] pre-
sented with hypocalcemia and proteinuria, which progressed
to a steroid resistant nephrotic syndrome, as well as with
hypoparathyroidism and bilateral nerve deafness. Renal his-
tology revealed fetal-like glomeruli and thickened glomerular
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Figure 2:Noncontrast computed tomography of the brain showed intracranial calcification involving the basal ganglia, thalamus, and cerebral
cortex on both the right (b) and left (a) sides.
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Figure 3: Pure tone audiometry showed bilateral moderate-to-severe hearing loss.
basementmembranes.The parathyroid glands were absent or
fibrotic. All four siblings died with end-stage renal disease
between the ages of 3 and 8. The patients reported by Bilous
et al. [1] had bilateral renal dysplasia. Hasegawa et al. [7]
found reports of 14 patients with deletion of 10p13; five
had hypoparathyroidism or hypocalcemia, 6 had urinary
tract abnormalities, and 2 had deafness. Fujimoto et al. [9]
reported a Japanese boy with associated recurrent cerebral
infarctions in the basal ganglia. Lichtner et al. [15] performed
molecular deletion analysis of two patients with partial
monosomy 10p and hypoparathyroidism, deafness and renal
dysplasia, or renal insufficiency, cardiac defect, cleft palate,
and reduced T-cell levels. Table 1 showed characteristics of
the reported cases of patients with HDR syndrome in the
literature.
Diagnosis is based on the clinical finding. Diagnosis of
suspected patients may be assisted by the following tests:
measurement of PTH levels, an audiogram or auditory brain
stem response study, renal imaging studies, and a renal
biopsy. DNA analysis may demonstrate the presence of a sub-
microscopic deletion on chromosome 10p. Detailed study
of chromosome 10p should be undertaken in patients with
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well-defined renal tract abnormality phenotypes, especially
when there is associated hypoparathyroidism or deafness [3].
Various combinations of this syndrome have been reported
including familial idiopathic hypoparathyroidism and pro-
gressive sensorineural deafness without renal disease [6,
8] and autosomal recessive hypoparathyroidism with renal
insufficiency and developmental delay [5]. Treatment con-
sists of treating the clinical abnormalities associated with
hypoparathyroidism, deafness, and renal disease at the time
of diagnosis. Prognosis depends on the nature and severity of
the renal disease.
Based on the findings of the present case, it is highly rec-
ommended that, in the patients presenting with seizure asso-
ciated with deafness, performing audiometry, calcium, phos-
phate, parathyroid hormone determination, and renal imag-
ing, studies can probably reveal this extremely rare genetic
disorder of Barakat syndrome.
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